card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
hero-bg-3211_Scientist wearing safety glasses

Bioanalytical Services

ADME / DMPK Services

Expertise for better development decisions

What is ADME?

 

ADME represents the lifecycle of what happens to a drug once it has been administered. In context of drug development, ADME refers to the suite of tests to assess Absorption, Distribution, Metabolism, and Excretion

 

Developing a potential drug candidate is an iterative process that requires careful planning to reach clinical trials. Most new drug candidates fail during preclinical and clinical development, and identifying those with promising ADME and pharmacokinetics properties during the discovery stage can streamline the development process. Preclinical ADME screening, drug metabolism, and pharmacokinetics assessments focus effort on potentially viable drug candidates, guiding decision-making from early discovery to Investigational New Drug (IND) filing and beyond. 

 

As an industry leader of clinical trial laboratory services, IQVIA Laboratories can help you make informed development decisions about your drug candidates by offering an array of high-throughput ADME screening and Drug Metabolism and Pharmacokinetics (DMPK) services that use validated bioanalytical methods to support candidate identification and characterization. Our ADME scientists have extensive expertise with high-throughput discovery bioanalysis and LC-MS bioanalysis platforms that enable various aspects of ADME testing and pharmacokinetic (PK) testing. From in vitro ADME screening assays and drug-drug interaction risk assessment to metabolite identification of in vitro and in vivo samples, IQVIA Laboratories services facilitate rapid drug discovery ADME property optimization and regulatory filings.

Our in vitro ADME laboratory can help you save time, reduce costs, and conserve resources in your drug discovery efforts

In vitro screening

 

In vitro screening plays a critical role in drug candidate optimization of ADME properties. Identifying the most promising drug candidates upfront accelerates the development cycle, reduces costs, streamlines the drug discovery pipeline, and guides subsequent pre-clinical and clinical studies. IQVIA Laboratories highly automated in vitro ADME laboratory offers a range of high-throughput ADME screening services to support the lead optimization stage of drug discovery, including assays for metabolic stability, cell permeability, and risk assessment for inhibiting cytochrome P450 enzymes.

 

To learn more about how IQVIA Laboratories ADME screening bundles and LC-MS bioanalytical capabilities can support your in vitro and pharmacokinetic (PK) testing please visit the links below:

 

In vitro metabolism

 
 

The ADME assay development pipeline includes in vitro ADME assays that are necessary once a lead candidate has been selected. The safety profile of a drug candidate will depend partly on its interactions with other drugs, especially those that may be administered concomitantly in standard-of-care treatment. Assessing the risks of possible drug-interactions using validated bioanalytical methods is thus an essential early step in the candidate development process. IQVIA Laboratories offers a suite of in vitro assays to support drug-drug interaction testing, including cytochrome P450 (CYP) enzyme inhibition (IC50), time-dependent CYP inhibition, induction of CYP enzymes, and CYP reaction phenotyping. All in vitro metabolism assay results are presented in fully QC-reviewed, regulatory-style reports to support filing of IND applications.

 

To learn more about how IQVIA Laboratories in vitro assay bundle can inform your drug-drug interaction testing efforts, please follow the link below:

Metabolite

 
 

Assessing a drug candidate’s metabolic profile early in the discovery process offers insight into its metabolic clearance pathways in both pre-clinical species and humans. IQVIA Laboratories global bioanalytical and ADME laboratory network offers a range of liquid chromatography/ mass spectrometry services to support discovery and development metabolite identification and profiling.

 

Specific capabilities using high-resolution mass spectrometry (HRMS) include:

  • Metabolite profiling and identification using liver microsomes or hepatocytes, as well as novel hepatocyte co-culture models for profiling slowly metabolized drug candidates
  • Exploratory profiling using unlabeled drug in preclinical and human clinical samples
  • Radio-profiling of both preclinical and human clinical samples
  • Reactive intermediate screens evaluating glutathione/cyanide trapping drug candidates (microsomes)

To explore how IQVIA Laboratories can partner to characterize metabolites in your study, please follow the link below:

 

Click here to learn more about our expansive expertise in Discovery Bioanalysis

Related Services

card-3222_Close up of test tubes with blood samples on stand

In Vitro Screening

Learn more
card-3270_young woman scientist in laboratory working

Early Hit-to-Lead ADME Screening Bundle

Learn more
card-3255_Female Research Scientist Putting Test Tubes with Blood Samples into Analyzer

High-Throughput ADME Services

Learn more
card-3232_Laboratory assistant putting test tubes into the holder

In Vitro Metabolism

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

Assessing your Drug-Drug Interaction Testing Risk

Learn more
card-3263_Hand in blue glove holding glass histology slides

Metabolite Identification and Profiling

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

ADME Assays & Metabolite Profiling and Identification Services

Learn more
card-3211_Scientist wearing safety glasses

Validated Assays

Learn more